Figure 1.
Algorithm showing the selection of study participants.
Study participants were selected after a review of records and laboratory results for all the patients who had CMV VL results during ICU stay, within the study period. CMV VL = cytomegalovirus viral load.
Figure 2.
Kaplan-Meier curve analysis showing survival probalities between the groups of patients: (A) who had CMV viral loads <1000 copies/ml compared to those who had viral loads >1000 copies/ml at baseline testing, (B) who had CMV viral loads <5000 copies/ml compared to those who had viral loads >5000 copies/ml at baseline testing, (C) who had CMV viral loads <10000 copies/ml compared to those who had viral loads >10000 copies/ml at baseline testing. HR = hazard ratio, CI = confidence interval.
Table 1.
Clinical characteristics of patients who had low CMV VL at baseline.
Table 2.
Clinical characteristics of patients who had undetectable CMV VL at baseline.
Table 3.
Characteristics of patients in different groups stratified by CMV VL of 5100 copies/ml and ganciclovir use.